Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer

Published:2021-09 Issue: Volume:22 Page:294-306
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Zheng Mingjun,Hu Yuexin,Gou Rui,Li Siting,Nie Xin,Li Xiao,Lin Bei

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference59 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

3. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur. J. Cancer,2013

4. The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis;Bendifallah;Am. J. Obstet. Gynocol.,2012

5. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer;Creasman;Int. J. Gynaecol. Obstet.,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq;The International Journal of Biological Markers;2024-04-22

2. The role and participation of immune cells in the endometrial tumor microenvironment;Pharmacology & Therapeutics;2023-11

3. A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC);Heliyon;2023-04

4. Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis;PLOS ONE;2023-01-20

5. Immunologic Signatures across Molecular Subtypes and Potential Biomarkers for Sub-Stratification in Endometrial Cancer;International Journal of Molecular Sciences;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3